173 related articles for article (PubMed ID: 24475260)
1. An upregulation in the expression of vanilloid transient potential channels 2 enhances hypotonicity-induced cytosolic Ca²⁺ rise in human induced pluripotent stem cell model of Hutchinson-Gillford Progeria.
Lo CY; Tjong YW; Ho JC; Siu CW; Cheung SY; Tang NL; Yu S; Tse HF; Yao X
PLoS One; 2014; 9(1):e87273. PubMed ID: 24475260
[TBL] [Abstract][Full Text] [Related]
2. Dysfunction of iPSC-derived endothelial cells in human Hutchinson-Gilford progeria syndrome.
Matrone G; Thandavarayan RA; Walther BK; Meng S; Mojiri A; Cooke JP
Cell Cycle; 2019 Oct; 18(19):2495-2508. PubMed ID: 31411525
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms of angiogenic incompetence in Hutchinson-Gilford progeria via downregulation of endothelial NOS.
Gete YG; Koblan LW; Mao X; Trappio M; Mahadik B; Fisher JP; Liu DR; Cao K
Aging Cell; 2021 Jul; 20(7):e13388. PubMed ID: 34086398
[TBL] [Abstract][Full Text] [Related]
4. TRPV2 channels mediate insulin secretion induced by cell swelling in mouse pancreatic β-cells.
Sawatani T; Kaneko YK; Doutsu I; Ogawa A; Ishikawa T
Am J Physiol Cell Physiol; 2019 Mar; 316(3):C434-C443. PubMed ID: 30649920
[TBL] [Abstract][Full Text] [Related]
5. A Tissue Engineered Blood Vessel Model of Hutchinson-Gilford Progeria Syndrome Using Human iPSC-derived Smooth Muscle Cells.
Atchison L; Zhang H; Cao K; Truskey GA
Sci Rep; 2017 Aug; 7(1):8168. PubMed ID: 28811655
[TBL] [Abstract][Full Text] [Related]
6. Hutchinson-Gilford progeria syndrome as a model for vascular aging.
Brassard JA; Fekete N; Garnier A; Hoesli CA
Biogerontology; 2016 Feb; 17(1):129-45. PubMed ID: 26330290
[TBL] [Abstract][Full Text] [Related]
7. iPSC-Derived Endothelial Cells Affect Vascular Function in a Tissue-Engineered Blood Vessel Model of Hutchinson-Gilford Progeria Syndrome.
Atchison L; Abutaleb NO; Snyder-Mounts E; Gete Y; Ladha A; Ribar T; Cao K; Truskey GA
Stem Cell Reports; 2020 Feb; 14(2):325-337. PubMed ID: 32032552
[TBL] [Abstract][Full Text] [Related]
8. Telomerase therapy reverses vascular senescence and extends lifespan in progeria mice.
Mojiri A; Walther BK; Jiang C; Matrone G; Holgate R; Xu Q; Morales E; Wang G; Gu J; Wang R; Cooke JP
Eur Heart J; 2021 Nov; 42(42):4352-4369. PubMed ID: 34389865
[TBL] [Abstract][Full Text] [Related]
9. TRPV channels mediate temperature-sensing in human corneal endothelial cells.
Mergler S; Valtink M; Coulson-Thomas VJ; Lindemann D; Reinach PS; Engelmann K; Pleyer U
Exp Eye Res; 2010 Jun; 90(6):758-70. PubMed ID: 20338165
[TBL] [Abstract][Full Text] [Related]
10. Vascular senescence in progeria: role of endothelial dysfunction.
Xu Q; Mojiri A; Boulahouache L; Morales E; Walther BK; Cooke JP
Eur Heart J Open; 2022 Jul; 2(4):oeac047. PubMed ID: 36117952
[TBL] [Abstract][Full Text] [Related]
11. Recapitulation of premature ageing with iPSCs from Hutchinson-Gilford progeria syndrome.
Liu GH; Barkho BZ; Ruiz S; Diep D; Qu J; Yang SL; Panopoulos AD; Suzuki K; Kurian L; Walsh C; Thompson J; Boue S; Fung HL; Sancho-Martinez I; Zhang K; Yates J; Izpisua Belmonte JC
Nature; 2011 Apr; 472(7342):221-5. PubMed ID: 21346760
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms controlling the smooth muscle cell death in progeria via down-regulation of poly(ADP-ribose) polymerase 1.
Zhang H; Xiong ZM; Cao K
Proc Natl Acad Sci U S A; 2014 Jun; 111(22):E2261-70. PubMed ID: 24843141
[TBL] [Abstract][Full Text] [Related]
13. Thermosensitive transient receptor potential channels in human corneal epithelial cells.
Mergler S; Garreis F; Sahlmüller M; Reinach PS; Paulsen F; Pleyer U
J Cell Physiol; 2011 Jul; 226(7):1828-42. PubMed ID: 21506114
[TBL] [Abstract][Full Text] [Related]
14. Increased mechanosensitivity and nuclear stiffness in Hutchinson-Gilford progeria cells: effects of farnesyltransferase inhibitors.
Verstraeten VL; Ji JY; Cummings KS; Lee RT; Lammerding J
Aging Cell; 2008 Jun; 7(3):383-93. PubMed ID: 18331619
[TBL] [Abstract][Full Text] [Related]
15. Lonafarnib and everolimus reduce pathology in iPSC-derived tissue engineered blood vessel model of Hutchinson-Gilford Progeria Syndrome.
Abutaleb NO; Atchison L; Choi L; Bedapudi A; Shores K; Gete Y; Cao K; Truskey GA
Sci Rep; 2023 Mar; 13(1):5032. PubMed ID: 36977745
[TBL] [Abstract][Full Text] [Related]
16. Modelling premature cardiac aging with induced pluripotent stem cells from a hutchinson-gilford Progeria Syndrome patient.
Monnerat G; Kasai-Brunswick TH; Asensi KD; Silva Dos Santos D; Barbosa RAQ; Cristina Paccola Mesquita F; Calvancanti Albuquerque JP; Raphaela PF; Wendt C; Miranda K; Domont GB; Nogueira FCS; Bastos Carvalho A; Campos de Carvalho AC
Front Physiol; 2022; 13():1007418. PubMed ID: 36505085
[TBL] [Abstract][Full Text] [Related]
17. Cellular stress and AMPK activation as a common mechanism of action linking the effects of metformin and diverse compounds that alleviate accelerated aging defects in Hutchinson-Gilford progeria syndrome.
Finley J
Med Hypotheses; 2018 Sep; 118():151-162. PubMed ID: 30037605
[TBL] [Abstract][Full Text] [Related]
18. Reprogramming progeria fibroblasts re-establishes a normal epigenetic landscape.
Chen Z; Chang WY; Etheridge A; Strickfaden H; Jin Z; Palidwor G; Cho JH; Wang K; Kwon SY; Doré C; Raymond A; Hotta A; Ellis J; Kandel RA; Dilworth FJ; Perkins TJ; Hendzel MJ; Galas DJ; Stanford WL
Aging Cell; 2017 Aug; 16(4):870-887. PubMed ID: 28597562
[TBL] [Abstract][Full Text] [Related]
19. Pluripotent stem cells to model Hutchinson-Gilford progeria syndrome (HGPS): Current trends and future perspectives for drug discovery.
Lo Cicero A; Nissan X
Ageing Res Rev; 2015 Nov; 24(Pt B):343-8. PubMed ID: 26474742
[TBL] [Abstract][Full Text] [Related]
20. Expression and distribution of three transient receptor potential vanilloid(TRPV) channel proteins in human odontoblast-like cells.
Wen W; Que K; Zang C; Wen J; Sun G; Zhao Z; Li Y
J Mol Histol; 2017 Dec; 48(5-6):367-377. PubMed ID: 28905239
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
